Ignite Creation Date:
2024-05-06 @ 12:40 AM
Last Modification Date:
2024-10-26 @ 10:53 AM
Study NCT ID:
NCT01637090
Status:
TERMINATED
Last Update Posted:
2017-01-12
First Post:
2012-04-02
Brief Title:
Everolimus in Treating Cutaneous T-cell Lymphoma
Sponsor:
Adam Lerner
Organization:
Boston Medical Center
Organization Data
Organization:
Boston Medical Center
Class:
OTHER
Study ID:
H-30213
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Adam Lerner
Lead Sponsor Class:
OTHER
Responsible Party:
Adam Lerner
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Boston Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |